Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

177 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunogenic cell stress and death.
Kroemer G, Galassi C, Zitvogel L, Galluzzi L. Kroemer G, et al. Among authors: galassi c. Nat Immunol. 2022 Apr;23(4):487-500. doi: 10.1038/s41590-022-01132-2. Epub 2022 Feb 10. Nat Immunol. 2022. PMID: 35145297 Review.
Stress responses in stromal cells and tumor homeostasis.
Vitale I, Manic G, Galassi C, Galluzzi L. Vitale I, et al. Among authors: galassi c. Pharmacol Ther. 2019 Aug;200:55-68. doi: 10.1016/j.pharmthera.2019.04.004. Epub 2019 Apr 16. Pharmacol Ther. 2019. PMID: 30998941 Review.
MDSCs sneak CSCs out of (immuno)surveillance.
Jiménez-Cortegana C, Galassi C, Galluzzi L. Jiménez-Cortegana C, et al. Among authors: galassi c. Trends Immunol. 2022 Jan;43(1):1-3. doi: 10.1016/j.it.2021.11.008. Epub 2021 Dec 2. Trends Immunol. 2022. PMID: 34863632
Myeloid-Derived Suppressor Cells and Radiotherapy.
Jiménez-Cortegana C, Galassi C, Klapp V, Gabrilovich DI, Galluzzi L. Jiménez-Cortegana C, et al. Among authors: galassi c. Cancer Immunol Res. 2022 May 3;10(5):545-557. doi: 10.1158/2326-6066.CIR-21-1105. Cancer Immunol Res. 2022. PMID: 35426936
Cytofluorometric assessment of cell cycle progression in irradiated cells.
Jiménez-Cortegana C, Klapp V, Bloy N, Galassi C, Sato A, Yamazaki T, Buqué A, Galluzzi L, Petroni G. Jiménez-Cortegana C, et al. Among authors: galassi c. Methods Cell Biol. 2022;172:1-16. doi: 10.1016/bs.mcb.2021.12.025. Epub 2022 Jan 17. Methods Cell Biol. 2022. PMID: 36064218
Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B.
Musella M, Guarracino A, Manduca N, Galassi C, Ruggiero E, Potenza A, Maccafeo E, Manic G, Mattiello L, Soliman Abdel Rehim S, Signore M, Pietrosanto M, Helmer-Citterich M, Pallocca M, Fanciulli M, Bruno T, De Nicola F, Corleone G, Di Benedetto A, Ercolani C, Pescarmona E, Pizzuti L, Guidi F, Sperati F, Vitale S, Macchia D, Spada M, Schiavoni G, Mattei F, De Ninno A, Businaro L, Lucarini V, Bracci L, Aricò E, Ziccheddu G, Facchiano F, Rossi S, Sanchez M, Boe A, Biffoni M, De Maria R, Vitale I, Sistigu A. Musella M, et al. Among authors: galassi c. Nat Immunol. 2022 Sep;23(9):1379-1392. doi: 10.1038/s41590-022-01290-3. Epub 2022 Aug 24. Nat Immunol. 2022. PMID: 36002648 Free PMC article.
177 results